Adial Pharmaceuticals, Inc. Interest Expense
Adial Pharmaceuticals, Inc. (ADIL) reported Interest Expense of $50.89 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-09-10.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2018-09-10
- Adial Pharmaceuticals, Inc. interest expense for the quarter ending 2018-06-30 was $50.89K, a 122.94% increase year-over-year.
- Adial Pharmaceuticals, Inc. interest expense for the quarter ending 2017-06-30 was $22.83K.
| Period end | Interest Expense 3 month | Interest Expense 6 month |
|---|---|---|
| 2018-06-30 | $50.89K 10-Q · filed 2018-09-10 | $102.57K 10-Q · filed 2018-09-10 |
| 2017-06-30 | $22.83K 10-Q · filed 2018-09-10 | $32.13K 10-Q · filed 2018-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |